Streetbeat News

Products Services

LLY

NVO

UL

Ben & Jerry's co-founders are not concerned about the impact of weight-loss drugs on their ice cream business, despite Unilever's plans to spin off its ice cream division. They believe ice cream is more about enjoyment than nutrition. Meanwhile, companies like Eli Lilly and Novo Nordisk are seeing increased demand for weight-loss drugs.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 5:38 am

MARA

Kaspa (KAS) surged 11% after Marathon Digital Holdings (MARA) announced it was mining the cryptocurrency to diversify from Bitcoin. Marathon has mined $16.74 million worth of KAS, amid challenging conditions for Bitcoin miners post-halving.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 5:32 am

BA

SPR

Boeing has refuted claims that NASA astronauts are stranded on its Starliner spacecraft, despite a delayed return from the ISS. The delay comes amid ongoing safety controversies for Boeing, including scrutiny over its 737 Max aircraft. Boeing's proposed acquisition of Spirit Aerosystems is seen as a positive move for recovery.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 3:47 am

MU

Micron Technology Inc. (NASDAQ:MU) saw an 8% drop in after-hours trading following its latest earnings report. Despite this, Gene Munster of Deepwater Asset Management remains optimistic about Micron's AI prospects, highlighting a projected 10-15% increase in High Bandwidth Memory (HBM) revenue next year. Micron's third-quarter earnings exceeded expectations, with $6.81 billion in revenue and 62 cents per share in adjusted earnings. The company plans to ramp up HBM production, aiming for a 20% market share next year.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 3:46 am

GBTC

HODL

IBIT

The SEC is expected to approve Ethereum spot ETFs by July 4, following successful Bitcoin spot ETFs. Asset managers like BlackRock, VanEck, and Grayscale are involved. Analysts predict a less impressive launch for Ethereum ETFs due to its smaller market cap and trading volumes.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 3:09 am

SSNLF

Samsung Electronics (OTC:SSNLF) is offering a $50 credit to customers who reserve the upcoming Galaxy Z Fold and Z Flip phones before their official release at the Unpacked event on July 10. This promotion comes as the foldable smartphone market experiences significant growth, with Samsung aiming to reclaim market leadership.

Portfolio Pulse from Ananya Gairola

June 27, 2024 | 2:23 am

AMZN

NVDA

The cryptocurrency market experienced a downturn due to fears of a $240 million Bitcoin sale by the U.S. government. Bitcoin, Ethereum, and Dogecoin all saw declines. Stocks, however, recorded gains, with Amazon and NVIDIA performing well. Analysts provided mixed forecasts for Bitcoin and the altcoin market.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 1:37 am

NVO

Bernie Sanders criticized the high pricing of the diabetes drug Ozempic, manufactured by Novo Nordisk (NYSE:NVO), suggesting that Americans are charged 10-15 times more than people in other countries. Sanders, who chairs the Senate HELP Committee, has previously criticized the drug's pricing and considered holding hearings on the issue. Novo Nordisk's CEO agreed to testify before the Senate after Sanders threatened to subpoena the company. Following Sanders' tweet, Novo Nordisk shares closed 2.2% lower.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 1:14 am

MNMD

Ovax Inc. has secured $10 million in funding to develop a groundbreaking fentanyl vaccine aimed at preventing fatal overdoses. The startup, founded by JR Rahn, who previously founded Mind Medicine Inc. (NASDAQ:MNMD), plans to begin human trials early next year. The vaccine aims to neutralize fentanyl's effects before they manifest, unlike naloxone which reverses overdoses after they occur.

Portfolio Pulse from Maureen Meehan

June 26, 2024 | 10:58 pm

MSOS

The U.S. dollar's recent strength poses challenges for cannabis investments, particularly the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS). Despite a recent 3% gain and a 14% recovery since last Monday, MSOS has faced significant volatility, including a 40% drop over six weeks. Key support levels at $7.50 and $7.30 have held firm, with resistance around $8.00. Broader market dynamics, regulatory hurdles, and competitive pressures continue to impact the cannabis sector.

Portfolio Pulse from Nicolás Jose Rodriguez

June 26, 2024 | 10:32 pm